Elena Castro is a medical oncologist and group leader at Hospital Universitario 12 de Octubre, in Madrid. 

Dr Castro received her medical degree and  PhD from the University of Salamanca.  After training in medical oncology, she completed a fellowship in cancer genetics and prostate cancer at the Institute of Cancer Research and The Royal Marsden Hospital, (London). In 2013, she returned to Spain and joined the Prostate Cancer Clinical Research Unit at the Spanish National Cancer Research Center (CNIO).

Dr Castro is a translational researcher whose interest range from preclinical studies to clinical trials. Her work has focused on the clinical implications of germline and genomic variants in prostate cancer. She has also been involved in numerous clinical trials investigating new treatment strategies for patients with prostate cancer.

Over her career, Dr Castro has received several grants and awards to support her research including an ESMO Research Fellowship (2010), the ESMO Best Fellowship Project Award (2016), and a Prostate Cancer Foundation Young Investigator Award (2017). She has authored over 100 peer-reviewed manuscripts, including several important papers on prostate cancer.

Dr Castro is part of the ESMO Faculty and a member of the ESMO Precision Oncology Working Group and the Communication Committee.